AGP Limited (AGP): Deregulation to boost 4QCY24 bottom-line - By JS Research
Jan 21 2025
JS Global Capital
- We preview 4QCY24 earnings for AGP Limited (AGP), where we expect earnings to register 71% YoY growth, arriving at Rs3.63/share mainly driven by higher prices post deregulation of non-essential medicines implemented majorly during 3QCY24, making 4Q the first quarter reflecting the major impact of the recent change. We also expect volumetric growth to support AGP’s bottom-line growth.
- Cumulatively, CY24E EPS (consolidated) accumulates to Rs8.89 (+59% YoY). Alongside results, we expect AGP to announce a final cash dividend of Rs3.5/share for CY24.
- The stock has rallied 49% in the past 3 months, however, has underperformed the Pharma sector. We believe the underperformance is unwarranted given the company’s higher earnings growth profile and attractive valuations. We reiterate our Buy rating for the stock, offering 36% upside to our Dec-2025 TP of Rs250.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low